Receptor recognition mechanisms of coronaviruses: A decade of structural studies

Journal of Virology

Volumn 89, Issue 4, 2015, Pages 1954-1964

  Li, Fang ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR; CORONAVIRUS RECEPTOR; CORONAVIRUS SPIKE GLYCOPROTEIN; PROTEIN BINDING; VIRUS RECEPTOR;

ALPHACORONAVIRUS; AMINO TERMINAL SEQUENCE; BETACORONAVIRUS; CARBOXY TERMINAL SEQUENCE; CORONAVIRUS; CRYSTAL STRUCTURE; HUMAN; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN STRUCTURE; RECEPTOR BINDING; SARS CORONAVIRUS; SHORT SURVEY; VIRUS ATTACHMENT; ANIMAL; CORONAVIRIDAE; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALIA; CORONAVIRUS;

ANIMALS; CORONAVIRUS; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; SPIKE GLYCOPROTEIN, CORONAVIRUS; VIRUS ATTACHMENT;

EID: 84921664670     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02615-14     Document Type: Short Survey

References (105)

1. Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7:439-450. http://dx.doi.org/10.1038/nrmicro2147.
2. Li WH, Wong SK, Li F, Kuhn JH, Huang IC, Choe H, Farzan M. 2006. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol 80:4211-4219. http://dx.doi.org/10.1128/JVI.80.9.4211-4219.2006.
3. González JM, Gomez-Puertas P, Cavanagh D, Gorbalenya AE, Enjuanes L. 2003. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol 148:2207-2235. http://dx.doi.org/10.1007/s00705-003-0162-1.
4. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong SX, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953-1966. http://dx.doi.org/10.1056/NEJMoa030781.
5. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT, Cheng VCC, Chan KH, Tsang DNC, Yung RWH, Ng TK, Yuen KY. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325. http://dx.doi.org/10.1016/S0140-6736(03)13077-2.
6. Marra MA, Jones SJM, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YSN, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JE, Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, et al. 2003. The genome sequence of the SARS-associated coronavirus. Science 300:1399-1404. http://dx.doi.org/10.1126/science.1085953.
7. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong SX, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TCT, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus A, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399. http://dx.doi.org/10.1126/science.1085952.
8. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus A, Fouchier RAM. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814-1820. http://dx.doi.org/10.1056/NEJMoa1211721.
9. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LL, Snijder EJ, Stephens GM, Woo PC, Zaki AM, Zambon M, Ziebuhr J. 2013. Middle East respiratory syndrome coronavirus (MERSCoV): announcement of the Coronavirus Study Group. J Virol 87:7790-7792. http://dx.doi.org/10.1128/JVI.01244-13.
10. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJM, Wolthers KC, Wertheim-van Dillen PME, Kaandorp J, Spaargaren J, Berkhout B. 2004. Identification of a new human coronavirus. Nat Med 10:368-373. http://dx.doi.org/10.1038/nm1024.
11. Fouchier RAM, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH, Osterhaus A. 2004. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 101:6212-6216. http://dx.doi.org/10.1073/pnas.0400762101.
12. Tajima M. 1970. Morphology of transmissible gastroenteritis virus of pigs. A possible member of coronaviruses. Brief report. Arch Gesamte Virusforsch 29:105-108.
13. Laude H, Rasschaert D, Delmas B, Godet M, Gelfi J, Charley B. 1990. Molecular biology of transmissible gastroenteritis virus. Vet Microbiol 23:147-154. http://dx.doi.org/10.1016/0378-1135(90)90144-K.
14. Taguchi F, Hirano N, Kiuchi Y, Fujiwara K. 1976. Difference in response to mouse hepatitis virus among susceptible mouse strains. Jpn J Microbiol 20:293-302. http://dx.doi.org/10.1111/j.1348-0421.1976.tb00991.x.
15. Hirai A, Ohtsuka N, Ikeda T, Taniguchi R, Blau D, Nakagaki K, Miura HS, Ami Y, Yamada YK, Itohara S, Holmes KV, Taguchi F. 2010. Role of mouse hepatitis virus (MHV) receptor murine CEACAM1 in the resistance of mice to MHV infection: studies of mice with chimeric mCEACAM1a and mCEACAM1b. J Virol 84:6654-6666. http://dx.doi.org/10.1128/JVI.02680-09.
16. Langpap TJ, Bergeland ME, Reed DE. 1979. Coronaviral enteritis of young calves: virologic and pathologic findings in naturally occurring infections. Am J Vet Res 40:1476-1478.
17. Vijgen L, Keyaerts E, Lemey P, Maes P, Van Reeth K, Nauwynck H, Pensaert M, Van Ranst M. 2006. Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43. J Virol 80:7270-7274. http://dx.doi.org/10.1128/JVI.02675-05.
18. Cavanagh D. 2007. Coronavirus avian infectious bronchitis virus. Vet Res 38:281-297. http://dx.doi.org/10.1051/vetres:2006055.
19. Cavanagh D. 2001. A nomenclature for avian coronavirus isolates and the question of species status. Avian Pathol 30:109-115. http://dx.doi.org/10.1080/03079450120044506.
20. Baranowski E, Ruiz-Jarabo CM, Domingo E. 2001. Evolution of cell recognition by viruses. Science 292:1102-1105. http://dx.doi.org/10.1126/science.1058613.
21. Bosch BJ, van der Zee R, de Haan CAM, Rottier PJM. 2003. The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J Virol 77:8801-8811. http://dx.doi.org/10.1128/JVI.77.16.8801-8811.2003.
22. Spaan W, Cavanagh D, Horzinek MC. 1988. Coronaviruses: structure and genome expression. J Gen Virol 69(Pt 12):2939-2952. http://dx.doi.org/10.1099/0022-1317-69-12-2939.
23. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569. http://dx.doi.org/10.1146/annurev.biochem.69.1.531.
24. Wilson IA, Skehel JJ, Wiley DC. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289: 366-373. http://dx.doi.org/10.1038/289366a0.
25. Eckert DM, Kim PS. 2001. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 70:777-810. http://dx.doi.org/10.1146/annurev.biochem.70.1.777.
26. Harrison SC. 2008. Viral membrane fusion. Nat Struct Mol Biol 15:690-698. http://dx.doi.org/10.1038/nsmb.1456.
27. Li F, Berardi M, Li WH, Farzan M, Dormitzer PR, Harrison SC. 2006. Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J Virol 80:6794-6800. http://dx.doi.org/10.1128/JVI.02744-05.
28. Beniac DR, Andonov A, Grudeski E, Booth TF. 2006. Architecture of the SARS coronavirus prefusion spike. Nat Struct Mol Biol 13:751-752. http://dx.doi.org/10.1038/nsmb1123.
29. Li F. 2012. Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits. J Virol 86:2856-2858. http://dx.doi.org/10.1128/JVI.06882-11.
30. Li F. 2013. Receptor recognition and cross-species infections of SARS coronavirus. Antiviral Res 100:246-254. http://dx.doi.org/10.1016/j.antiviral.2013.08.014.
31. Du LY, He YX, Zhou YS, Liu SW, Zheng BJ, Jiang SB. 2009. The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nat Rev Microbiol 7:226-236. http://dx.doi.org/10.1038/nrmicro2090.
32. Du L, Zhao G, Yang Y, Qiu H, Wang L, Kou Z, Tao X, Yu H, Sun S, Tseng CT, Jiang S, Li F, Zhou Y. 2014. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptorbinding domain in Middle East respiratory syndrome coronavirus spike protein. J Virol 88:7045-7053. http://dx.doi.org/10.1128/JVI.00433-14.
33. He YX, Lu H, Siddiqui P, Zhou YS, Jiang SB. 2005. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol 174:4908-4915. http://dx.doi.org/10.4049/jimmunol.174.8.4908.
34. Ying T, Du L, Ju TW, Prabakaran P, Lau CC, Lu L, Liu Q, Wang L, Feng Y, Wang Y, Zheng BJ, Yuen KY, Jiang S, Dimitrov DS. 2014. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol 88:7796-7805. http://dx.doi.org/10.1128/JVI.00912-14.
35. Jiang L, Wang N, Zuo T, Shi X, Poon KM, Wu Y, Gao F, Li D, Wang R, Guo J, Fu L, Yuen KY, Zheng BJ, Wang X, Zhang L. 2014. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med 6:234ra59. http://dx.doi.org/10.1126/scitranslmed.3008140.
36. Sui JH, Li WH, Murakami A, Tamin A, Matthews LJ, Wong SK, Moore MJ, Tallarico ASC, Olurinde M, Choe H, Anderson LJ, Bellini WJ, Farzan M, Marasco WA. 2004. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad SciUS A 101:2536-2541. http://dx.doi.org/10.1073/pnas.0307140101.
37. Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. 2005. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad SciUS A 102:7988-7993. http://dx.doi.org/10.1073/pnas.0409465102.
38. Li WH, Moore MJ, Vasilieva N, Sui JH, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454. http://dx.doi.org/10.1038/nature02145.
39. Wong SK, Li WH, Moore MJ, Choe H, Farzan M. 2004. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 279:3197-3201. http://dx.doi.org/10.1074/jbc.C300520200.
40. Lin HX, Fen Y, Wong G, Wang LP, Li B, Zhao XS, Li Y, Smaill F, Zhang CS. 2008. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction. J Gen Virol 89:1015-1024. http://dx.doi.org/10.1099/vir.0.83331-0.
41. Hofmann H, Simmons G, Rennekamp AJ, Chaipan C, Gramberg T, Heck E, Geier M, Wegele A, Marzi A, Bates P, Pohlmann S. 2006. Highly conserved regions within the spike proteins of human coronaviruses 229E andNL63determine recognition of their respective cellular receptors. J Virol 80:8639-8652. http://dx.doi.org/10.1128/JVI.00560-06.
42. Babcock GJ, Esshaki DJ, Thomas WD, Ambrosino DM. 2004. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 78:4552-4560. http://dx.doi.org/10.1128/JVI.78.9.4552-4560.2004.
43. Xiao XD, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS. 2003. The SARS-CoV S glycoprotein: expression and functional characterization. Biochem Biophys Res Commun 312:1159-1164. http://dx.doi.org/10.1016/j.bbrc.2003.11.054.
44. Delmas B, Gelfi J, Lharidon R, Vogel LK, Sjostrom H, Noren O, Laude H. 1992. Aminopeptidase-N is a major receptor for the enteropathogenic coronavirus TGEV. Nature 357:417-420. http://dx.doi.org/10.1038/357417a0.
45. Godet M, Grosclaude J, Delmas B, Laude H. 1994. Major receptorbinding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J Virol 68:8008-8016.
46. Raj VS, Mou HH, Smits SL, Dekkers DHW, Muller MA, Dijkman R, Muth D, Demmers JAA, Zaki A, Fouchier RAM, Thiel V, Drosten C, Rottier PJM, Osterhaus A, Bosch BJ, Haagmans BL. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251-254. http://dx.doi.org/10.1038/nature12005.
47. Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, Zhou Y, Jiang S. 2013. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol 87: 9939-9942. http://dx.doi.org/10.1128/JVI.01048-13.
48. Mou H, Raj VS, van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ. 19 June 2013. The receptor binding domain of the new MERS coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol http://dx.doi.org/10.1128/JVI.01277-13.
49. Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang GS, Holmes KV, Dieffenbach CW. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J Virol 65:6881-6891.
50. Williams RK, Jiang GS, Holmes KV. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci USA 88:5533-5536. http://dx.doi.org/10.1073/pnas.88.13.5533.
51. Schultze B, Gross HJ, Brossmer R, Herrler G. 1991. The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant. J Virol 65:6232-6237.
52. Kubo H, Yamada YK, Taguchi F. 1994. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol 68:5403-5410.
53. Peng GQ, Xu LQ, Lin YL, Chen L, Pasquarella JR, Holmes KV, Li F. 2012. Crystal structure of bovine coronavirus spike protein lectin domain. J Biol Chem 287:41931-41938. http://dx.doi.org/10.1074/jbc.M112.418210.
54. Krempl C, Schultze B, Laude H, Herrler G. 1997. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol 71: 3285-3287.
55. Schultze B, Cavanagh D, Herrler G. 1992. Neuraminidase treatment of avian infectious-bronchitis coronavirus reveals a hemagglutinating activity that is dependent on sialic acid-containing receptors on erythrocytes. Virology 189:792-794. http://dx.doi.org/10.1016/0042-6822(92)90608-R.
56. Cavanagh D, Davis PJ. 1986. Coronavirus IBV: removal of spike glycopolypeptide S1 by urea abolishes infectivity and hemagglutination but not attachment to cells. J Gen Virol 67:1443-1448. http://dx.doi.org/10.1099/0022-1317-67-7-1443.
57. Schwegmann-Wessels C, Herrler G. 2006. Sialic acids as receptor determinants for coronaviruses. Glycoconj J 23:51-58. http://dx.doi.org/10.1007/s10719-006-5437-9.
58. Promkuntod N, van Eijndhoven RE, de Vrieze G, Grone A, Verheije MH. 2014. Mapping of the receptor-binding domain and amino acids critical for attachment in the spike protein of avian coronavirus infectious bronchitis virus. Virology 448:26-32. http://dx.doi.org/10.1016/j.virol.2013.09.018.
59. Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, Ryan D, Fisher M, Williams D, Dales NA, Patane MA, Pantoliano MW. 2004. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279:17996-18007. http://dx.doi.org/10.1074/jbc.M311191200.
60. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. 2000. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87:E1-E9. http://dx.doi.org/10.1161/01.RES.87.5.e1.
61. Keidar S, Kaplan M, Gamliel-Lazarovich A. 2007. ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc Res 73:463-469. http://dx.doi.org/10.1016/j.cardiores.2006.09.006.
62. Boehm M, Nabel EG. 2002. Angiotensin-converting enzyme 2-a new cardiac regulator. N Engl J Med 347:1795-1797. http://dx.doi.org/10.1056/NEJMcibr022472.
63. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang CY, Penninger JM. 2005. Angiotensinconverting enzyme 2 protects from severe acute lung failure. Nature 436:112-116. http://dx.doi.org/10.1038/nature03712.
64. Kuba K, Imai Y, Rao SA, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang YL, Deng W, Bao LL, Zhang BL, Liu G, Wang Z, Chappell M, Liu YX, Zheng DX, Leibbrandt A, Wada T, Slutsky AS, Liu DP, Qin CA, Jiang CY, Penninger JM. 2005. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11:875-879. http://dx.doi.org/10.1038/nm1267.
65. Chen L, Lin YL, Peng GQ, Li F. 2012. Structural basis for multifunctional roles of mammalian aminopeptidase N. Proc Natl Acad Sci USA 109:17966-17971. http://dx.doi.org/10.1073/pnas.1210123109.
66. Mina-Osorio P. 2008. The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med 14:361-371. http://dx.doi.org/10.1016/j.molmed.2008.06.003.
67. Rasmussen HB, Branner S, Wiberg FC, Wagtmann N. 2003. Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat Struct Biol 10:19-25. http://dx.doi.org/10.1038/nsb882.
68. Reinhold D, Kahne T, Steinbrecher A, Wrenger S, Neubert K, Ansorge S, Brocke S. 2002. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity. Biol Chem 383:1133-1138.
69. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C. 1993. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466-469. http://dx.doi.org/10.1126/science.8101391.
70. Wesley UV, McGroarty M, Homoyouni A. 2005. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res 65:1325-1334. http://dx.doi.org/10.1158/0008-5472.CAN-04-1852.
71. Tan KM, Zelus BD, Meijers R, Liu JH, Bergelson JM, Duke N, Zhang R, Joachimiak A, Holmes KV, Wang JH. 2002. Crystal structure of murine sCEACAM1a 1,4: a coronavirus receptor in the CEA family. EMBO J 21:2076-2086. http://dx.doi.org/10.1093/emboj/21.9.2076.
72. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F, Hammarstrom S, Holmes KV, Karlsson A, Kuroki M, Lin SH, Lucka L, Najjar SM, Neumaier M, Obrink B, Shively JE, Skubitz KM, Stanners CP, Thomas P, Thompson JA, Virji M, von Kleist S, Wagener C, Watt S, Zimmermann W. 1999. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 252:243-249. http://dx.doi.org/10.1006/excr.1999.4610.
73. Hammarström S. 1999. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9:67-81. http://dx.doi.org/10.1006/scbi.1998.0119.
74. Dove A. 2001. The bittersweet promise of glycobiology. Nat Biotechnol 19:913-917. http://dx.doi.org/10.1038/nbt1001-913.
75. Ghazarian H, Idoni B, Oppenheimer SB. 2011. A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem 113:236-247. http://dx.doi.org/10.1016/j.acthis.2010.02.004.
76. Li F, Li WH, Farzan M, Harrison SC. 2005. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864-1868. http://dx.doi.org/10.1126/science.1116480.
77. Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J, Zhang B, Shi Y, Yan J, Gao GF. 2013. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500:227-231. http://dx.doi.org/10.1038/nature12328.
78. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, Guo D, Fu L, Cui Y, Liu X, Arledge KC, Chen YH, Zhang L, Wang X. 2013. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 23:986-993. http://dx.doi.org/10.1038/cr.2013.92.
79. Wu K, Li WB, Peng G, Li F. 2009. Crystal structure of NL63 respiratory coronavirus receptor-binding complexed with its human receptor. Proc Natl Acad Sci USA 106:19970-19974. http://dx.doi.org/10.1073/pnas.0908837106.
80. Reguera J, Santiago C, Mudgal G, Ordono D, Enjuanes L, Casasnovas JM. 2012. Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathog 8:e1002859. http://dx.doi.org/10.1371/journal.ppat.1002859.
81. Peng GQ, Sun DW, Rajashankar KR, Qian ZH, Holmes KV, Li F. 2011. Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. Proc Natl Acad Sci USA 108: 10696-10701. http://dx.doi.org/10.1073/pnas.1104306108.
82. Wang Q, Qi J, Yuan Y, Xuan Y, Han P, Wan Y, Ji W, Li Y, Wu Y, Wang J, Iwamoto A, Woo PC, Yuen KY, Yan J, Lu G, Gao GF. 2014. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16:328-337. http://dx.doi.org/10.1016/j.chom.2014.08.009.
83. Li F. 2008. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. J Virol 82:6984-6991. http://dx.doi.org/10.1128/JVI.00442-08.
84. Wu KL, Peng GQ, Wilken M, Geraghty RJ, Li F. 2012. Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus. J Biol Chem 287:8904-8911. http://dx.doi.org/10.1074/jbc.M111.325803.
85. Li F, Li WH, Farzan M, Harrison SC. 2006. Interactions between SARS coronavirus and its receptor. Adv Exp Med Biol 581:229-234. http://dx.doi.org/10.1007/978-0-387-33012-9_38.
86. Li WH, Zhang CS, Sui JH, Kuhn JH, Moore MJ, Luo SW, Wong SK, Huang IC, Xu KM, Vasilieva N, Murakami A, He YQ, Marasco WA, Guan Y, Choe HY, Farzan M. 2005. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 24:1634-1643. http://dx.doi.org/10.1038/sj.emboj.7600640.
87. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, Zhou HQ, Xiang H, Zheng HJ, Chern SW, Cheng F, Pan CM, Xuan H, Chen SJ, Luo HM, Zhou DH, Liu YF, He JF, Qin PZ, Li LH, Ren YQ, Liang WJ, Yu YD, Anderson L, Wang M, Xu RH, Wu XW, Zheng HY, Chen JD, Liang G, Gao Y, Liao M, Fang L, Jiang LY, Li H, Chen F, Di B, He LJ, Lin JY, Tong S, Kong X, Du L, Hao P, Tang H, Bernini A, Yu XJ, Spiga O, Guo ZM, et al. 2005. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA 102:2430-2435. http://dx.doi.org/10.1073/pnas.0409608102.
88. Qu XX, Hao P, Song XJ, Jiang SM, Liu YX, Wang PG, Rao X, Song HD, Wang SY, Zuo Y, Zheng AH, Luo M, Wang HL, Deng F, Wang HZ, Hu ZH, Ding MX, Zhao GP, Deng HK. 2005. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. J Biol Chem 280:29588-29595. http://dx.doi.org/10.1074/jbc.M500662200.
89. Hou YX, Peng C, Yu M, Li Y, Han ZG, Li F, Wang LF, Shi ZL. 2010. Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. Arch Virol 155: 1563-1569. http://dx.doi.org/10.1007/s00705-010-0729-6.
90. Wu K, Chen L, Peng G, Zhou W, Pennell CA, Mansky LM, Geraghty RJ, Li F. 2011. A virus-binding hot spot on human angiotensinconverting enzyme 2 is critical for binding of two different coronaviruses. J Virol 85:5331-5337. http://dx.doi.org/10.1128/JVI.02274-10.
91. Liu L, Fang Q, Deng F, Wang HZ, Yi CE, Ba L, Yu WJ, Lin RD, Li TS, Hu ZH, Ho DD, Zhang LQ, Chen ZW. 2007. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of crossneutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J Virol 81:4694-4700. http://dx.doi.org/10.1128/JVI.02389-06.
92. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu B, Zhang W, Peng C, Zhang YJ, Luo CM, Tan B, Wang N, Zhu Y, Crameri G, Zhang SY, Wang LF, Daszak P, Shi ZL. 2013. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503:535-538. http://dx.doi.org/10.1038/nature12711.
93. Chen YQ, Rajashankar KR, Yang Y, Agnihothram SS, Liu C, Lin YL, Baric RS, Li F. 2013. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol 87:10777-10783. http://dx.doi.org/10.1128/JVI.01756-13.
94. Yang Y, Du L, Liu C, Wang L, Ma C, Tang J, Baric RS, Jiang S, Li F. 2014. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci USA 111:12516-12521. http://dx.doi.org/10.1073/pnas.1405889111.
95. Cockrell AS, Peck KM, Yount BL, Agnihothram SS, Scobey T, Curnes NR, Baric RS, Heise MT. 2014. Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection. J Virol 88:5195-5199. http://dx.doi.org/10.1128/JVI.03764-13.
96. van Doremalen N, Miazgowicz KL, Milne-Price S, Bushmaker T, Robertson S, Scott D, Kinne J, McLellan JS, Zhu J, Munster VJ. 2014. Host species restriction of Middle East respiratory syndrome coronavirus through Its receptor, dipeptidyl peptidase 4. J Virol 88:9220-9232. http://dx.doi.org/10.1128/JVI.00676-14.
97. Barlan A, Zhao J, Sarkar MK, Li K, McCray PB, Jr, Perlman S, Gallagher T. 2014. Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol 88:4953-4961. http://dx.doi.org/10.1128/JVI.00161-14.
98. Holm L, Sander C. 1998. Touring protein fold space with Dali/FSSP. Nucleic Acids Res 26:316-319. http://dx.doi.org/10.1093/nar/26.1.316.
99. Seetharaman J, Kanigsberg A, Slaaby R, Leffler H, Barondes SH, Rini JM. 1998. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-angstrom resolution. J Biol Chem 273:13047-13052. http://dx.doi.org/10.1074/jbc.273.21.13047.
100. Wessner DR, Shick PC, Lu JH, Cardellichio CB, Gagneten SE, Beauchemin N, Holmes KV, Dveksler GS. 1998. Mutational analysis of the virus and monoclonal antibody binding sites in MHVR, the cellular receptor of the murine coronavirus mouse hepatitis virus strain A59. J Virol 72:1941-1948.
101. Thackray LB, Turner BC, Holmes KV. 2005. Substitutions of conserved amino acids in the receptor-binding domain of the spike glycoprotein affect utilization of murine CEACAM1a by the murine coronavirus MHV-A59. Virology 334:98-110. http://dx.doi.org/10.1016/j.virol.2005.01.016.
102. Leparc-Goffart I, Hingley ST, Chua MM, Jiang XH, Lavi E, Weiss SR. 1997. Altered pathogenesis of a mutant of the murine coronavirusMHVA59 is associated with a Q159L amino acid substitution in the spike protein. Virology 239:1-10. http://dx.doi.org/10.1006/viro.1997.8877.
103. Chen L, Li F. 2013. Structural analysis of the evolutionary origins of influenza virus hemagglutinin and other viral lectins. J Virol 87:4118-4120. http://dx.doi.org/10.1128/JVI.03476-12.
104. Rossmann MG. 1989. The canyon hypothesis. Hiding the host-cell receptor attachment site on a viral surface from immune surveillance. J Biol Chem 264:14587-14590.
105. Wang J. 2002. Protein recognition by cell surface receptors: physiological receptors versus virus interactions. Trends Biochem Sci 27:122-126. http://dx.doi.org/10.1016/S0968-0004(01)02038-2.